These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 799855)

  • 1. [Increase in the concentration of effector T-lymphocytes specific for H-2 antigens. II. Removal of B-lymphocytes from an eluted population of cytotoxic T-cells].
    Brondz BD; Egorova SG; Kotomina IF
    Tsitologiia; 1976 Dec; 18(12):1484-9. PubMed ID: 799855
    [No Abstract]   [Full Text] [Related]  

  • 2. Fc-rosetting and nonrosetting T cells are killer cells.
    Krammer PH; Elliott BE; von Boehmer H
    Eur J Immunol; 1976 Feb; 6(2):138-9. PubMed ID: 1085703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of mononuclear effector cells in human blood.
    Hersey P; Edwards A; Edwards J
    Clin Exp Immunol; 1976 Jan; 23(1):104-13. PubMed ID: 1083316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of cytotoxic t-lymphocytes eluted from allogenic target cells].
    Egorov SG; Brondz BD
    Biull Eksp Biol Med; 1977 Jan; 83(1):50-3. PubMed ID: 322755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary cytotoxic cell response to lymphocytic choriomeningitis virus II. Nature and specificity of effector cells.
    Dunlop MB; Doherty PC; Zinkernagel RM; Blanden RV
    Immunology; 1976 Aug; 31(2):181-6. PubMed ID: 1085282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface immunoglobulin on H-2-activated T lymphocytes.
    Sprent J; Hudson L
    Transplant Proc; 1973 Dec; 5(4):1731-3. PubMed ID: 4544163
    [No Abstract]   [Full Text] [Related]  

  • 7. Enrichment of effector T lymphocytes specific to H-2 antigens by elution from allogeneic target cells and characterization of the eluted lymphocyte population.
    Brondz BD; Egorova SG; Kotomina IF
    Eur J Immunol; 1975 Nov; 5(11):773-41. PubMed ID: 829900
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell-mediated immunity to H-2 antigens. Characteristics of the effector cells as detected in the microcytotoxicity assay.
    Trostmann H; Pfizenmaier K; Wagner H; Röllinghoff M
    Transplantation; 1976 Jun; 21(6):446-53. PubMed ID: 1084606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Origin of effector and rosette-forming cells in transplantation immunity in mice].
    Brondz BD; Kotomina IF
    Biull Eksp Biol Med; 1973 Sep; 76(9):69-72. PubMed ID: 4130411
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhancement of T. lymphocyte functions by Fc fragments of immunoglobulin. II. Augmentation of the cell-mediated lympholysis response occurs through an Lyt-1+2- helper T cell.
    Morgan EL; Thoman ML; Weigle WO
    J Immunol; 1981 Dec; 127(6):2526-30. PubMed ID: 6457879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated cytotoxicity in vitro: target-cell recognition and effector-cell requirements.
    Perlmann P; Holm G; Stejskal V
    Transplant Proc; 1973 Dec; 5(4):1625-9. PubMed ID: 4272822
    [No Abstract]   [Full Text] [Related]  

  • 12. Fc fragment activation of T lymphocytes. I. Fc fragments trigger Lyt 1+23- T lymphocytes to release a helper T cell-replacing activity.
    Thoman ML; Morgan EL; Weigle WO
    J Immunol; 1981 Feb; 126(2):632-5. PubMed ID: 6969757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The syngeneic T-T lymphocyte reaction (STTLR). II. Induction of primary T anti-T cell cytotoxic responses in vitro in T cell cultures stimulated with syngeneic self-reactive T cells.
    Suzuki H; Quintáns J
    J Mol Cell Immunol; 1986; 2(6):345-57. PubMed ID: 3509919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T lymphocyte responses to non-H-2 histocompatibility antigens. I. Role of Ly-1+2+ T cells as cytotoxic effectors and requirement for Ly-1+2+ T cells for optimal generation of cytotoxic effectors.
    Wettstein PJ; Frelinger JA
    J Immunol; 1981 Jul; 127(1):43-6. PubMed ID: 6165773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of T lymphocytes from normal individuals and patients with B lymphocyte chronic lymphocytic leukaemia.
    Fernandez LA; MacSween JM; Langley GR
    Immunology; 1975 Feb; 28(2):231-41. PubMed ID: 1091543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific adsorption of cytotoxic thymus-processed lymphocytes (T cells) on glutaraldehyde-fixed fibroblast monolayers.
    Golstein P; Svedmyr EA; Blomgren H
    Eur J Immunol; 1972 Aug; 2(4):380-3. PubMed ID: 4628413
    [No Abstract]   [Full Text] [Related]  

  • 17. Human lymphocyte cytotoxicity against mumps virus-infected target cells. Requirement for non-T cells.
    Härfast B; Andersson T; Perlmann P
    J Immunol; 1975 Jun; 114(6):1820-3. PubMed ID: 1168673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T and B membrane markers on blast cells in 69 patients with acute lymphoblastic leukemia.
    Brouet JC; Toben HR; Chevalier A; Seligmann M
    Ann Immunol (Paris); 1974; 125 C(5):691-6. PubMed ID: 4617552
    [No Abstract]   [Full Text] [Related]  

  • 19. Functional properties of T and B lymphocytes in cell-mediated immunity.
    Petrányl GG
    Haematologia (Budap); 1974; 8(1-4):361-82. PubMed ID: 4142621
    [No Abstract]   [Full Text] [Related]  

  • 20. Electrophoretic fractionation of mouse T and B lymphocytes. Efficiency of the method and purity of separated cells.
    Häyry P; Andersson LC; Nordling S
    Transplant Proc; 1973 Mar; 5(1):87-90. PubMed ID: 4572149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.